For research teamsHelp me find a study
Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 4,861-4,872 of 6,115
Drug study icon
CompletedNCT03427892

Brexpiprazole for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity, Depression
View study
Behavioral study icon
CompletedNCT04672798

BRITEPath- Phase 2

This study is completed in the United States. It focuses on Suicide prevention.

Multiple locations, including Detroit
Why is this study shown?

This study includes Depression among several conditions.

Suicidality, DepressionBehavioralFrom 12 Years to 26 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Suicidality, Depression
View study
Behavioral study icon
CompletedNCT01191788

Building Recovery By Improving Goals, Habits, and Thoughts

This summary needs review. Please check the official study record and contact the research team for details.

In Gardena
Why is this study shown?

This study includes Depression among several conditions.

Addiction, DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
RAND
Condition
Addiction, Depression
View study
Drug study icon
WithdrawnNCT04430959

Candesartan as an Adjunctive Treatment for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Bipolarity, Depression
View study
Drug study icon
TerminatedNCT03310593

Cannabidiol as an Adjunctive Treatment for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Porto Alegre
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 70 Years
Countries
Brazil
Sponsor
Hospital de Clinicas de Porto Alegre
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedNCT00203567

Carbamazepine Extended-Release for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Tuscaloosa
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 19 Years to 65 Years
Countries
United States
Sponsor
Tuscaloosa Research & Education Advancement Corporation
Condition
Bipolarity, Depression
View study
Drug study icon
TerminatedNCT00566111

Ceftriaxone in the Management of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Bipolarity, Depression
View study
Other study type icon
CompletedNCT01784341

Circadian Phase in Depression in bipolarity: Is it Delayed and Does it Normalize With Remission?

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 55 Years
Countries
United States
Sponsor
Northwestern University
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedNCT02600494

study Evaluating ITI-007 (Lumateperone) as a Monotherapy for Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedNCT02600507

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Depression for depression in bipolarity

This study is completed in the United States, in Bulgaria, in Russia, .... It is testing Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Depression for depression in bipolarity.

Multiple locations, including Rogers
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, Bulgaria, Russia, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity, Depression
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.